Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

US Congress

This page shows the latest US Congress news and features for those working in and with pharma, biotech and healthcare.

Roche says ‘discovery proteomics’ is heading for clinical trials

Roche says ‘discovery proteomics’ is heading for clinical trials

A study presented at the Mass Spectrometry Applications to the Clinical Lab (MSACL) congress in the US last week by Roche and Biognosys scientists looked at how ‘discovery proteomics’ performed in

Latest news

  • GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

    This included a $3bn fine imposed on GSK after it was caught promoting Advair off-label in the US, with a corporate integrity agreement imposed on it by US regulators. ... It will also return to paying travel costs for HCPs to attend GSK’s own

  • FDA moves to tackle orphan designation backlog FDA moves to tackle orphan designation backlog

    The US regulator's Orphan Drug Modernisation Plan aims to eliminate the waiting list, and is the first development under the FDA's new Medical Innovation Development Plan. ... Congress gave us tools to incentivise the development of novel therapies for

  • The tribe has spoken The tribe has spoken

    Who gets to decide which profit margin is acceptable? Reality TV has given us countless catchphrases and memorable pop culture idioms and Jeff Probst's final words to the ousted Survivor ... Forget, for a moment, about the fact that for this to happen it

  • Alexion's rare bone disorder therapy rejected by NICE Alexion's rare bone disorder therapy rejected by NICE

    In the US the drug has been priced at an average $285, 000 a year - well below the level expected by analysts - with some suggesting the company may have been spooked ... The US decision may signal that Alexion is prepared to be flexible on Strensiq's

  • Who is the marketer of the future? Who is the marketer of the future?

    In the past getting 1-5 articles a year published and obtaining good congress coverage in Europe and US was considered successful. ... It is therefore essential for us to have resources and people dedicated to developing content constantly and who are

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    A US survey that has been undertaken every year since the early 1990s provides some illumination as to the specialties that residents and fellows completing their training in New York State ... A brief glance at the programme for the major US haematology

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Attracting doctors to low-demand specialties: A role for industry?

    A US survey that has been undertaken every year since the early 1990s provides some illumination as to the specialties that residents and fellows completing their training in New York State ... A brief glance at the programme for the major US haematology

  • EULAR Annual European Congress of Rheumatology 2017

    Join us at EULAR Congress 2017 in Madrid, 14-17 June. We are delighted to be attending and presenting at this year’s EULAR Annual European Congress of Rheumatology in June.

  • Research Partnership

    Research Partnership is today expanding its US operations across both the West and East Coast. ... Visit us on stand number 14. Join us at EULAR Congress 2017 in Madrid, 14-17 June.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Quick links

Infographics

Multimedia